Lazertinib Versus Gefitinib as First-line Treatment in Patients With EGFR -mutated Advanced Non-Small Cell Lung Cancer (NSCLC): Results From LASER301.
Byoung Chul ChoMyung-Ju AhnJin Hyoung KangRoss Andrew SooThanyanan ReungwetwattanaJames Chih-Hsin YangIrfan CicinDong Wan KimYi-Long WuShun LuKi Hyeong LeeYong-Kek PangAnastasia ZiminaChin Heng FongElena PoddubskayaAhmet SezerSoon Hin HowPongwut DanchaivijitrYuKyung KimYeji LimTaewon AnHana LeeHae Mi ByunBojan ZarićPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
-mutated advanced NSCLC, with a manageable safety profile.